Citius Oncology, Inc. CTOR Increase (decrease) in due to related parties
Increase (decrease) in due to related parties at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDueToRelatedParties.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s increase (decrease) in due to related parties.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s increase (decrease) in due to related parties?
- Citius Oncology, Inc. (CTOR) reported increase (decrease) in due to related parties of -$3.27M in Q1 2026.
- How has Citius Oncology, Inc.'s increase (decrease) in due to related parties changed year-over-year?
- Citius Oncology, Inc.'s increase (decrease) in due to related parties decreased by 260.0% year-over-year, from $2.05M to -$3.27M.
- What does increase (decrease) in due to related parties mean?
- Tracks the net change in financial obligations owed to affiliated entities, subsidiaries, or key management personnel. Fluctuations in this balance provide insight into intercompany financing activities and the reliance on related parties for operational support.